Nextmune is a global, science-driven company specializing in pet pharmaceutical products. The company is focused on developing, manufacturing and commercializing pet health solutions with expertise in allergy, dermatology, gastroenterology and several other specialty areas.
Nextmune was formed through the merger of ICF (International Clinical Formulations) and DRN (Development Research Nutrition). Both companies brought their expertise in veterinary medicine and specialized pet nutrition, making Nextmune a global leader in allergy and dermatology solutions for pets.
Known for challenging conventional wisdom and developing innovative diagnostics and products that improve the quality of life for pets, Nextmune is a leading company in specialized pet care. With a presence in over 70 countries and products available through veterinary clinics, retailers and online stores, Nextmune is a leading company in specialized pet care.
